CDNA vs LNTH: fair value comparison
CareDx, Inc. and Lantheus Holdings, Inc. · Updated 2026-09-07
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, LNTH currently sits closer to the top of our discount ranking.
| CDNA | LNTH | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $47.85 | $101.19 |
| 12-month range | $14.77–$47.85 | $51.63–$108.96 |
| Sector rank | #107 of 113 Healthcare | #102 of 113 Healthcare |
| Quality grade | A | A |
| Leverage | Low | Moderate |
| Margin trend | Expanding | Contracting |
| Revenue growth | Modest | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | Mixed |
| DCF cross-check | — | Fairly Valued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: CDNA fair value analysis · LNTH fair value analysis